[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355902-105":59,"doc-detail-355902-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","deep-unsupervised-domain-adaptation-for-translating-cancer-dependency-maps-from-cell-lines-to-breast-cancer-tumor-genomics","Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics","","The Cancer dependency maps (DepMap) identify genetic dependencies in cancer cells using large-scale loss-of-function screens, enabling cancer-specific treatment strategies. Gaps remain when translating results from cancer cell line models to patient-derived tumor biology. A deep unsupervised domain adaptation (UDA) method is developed to align source-domain labeled cell line features with target-domain unlabeled cell line data. The model predicts breast cancer dependency maps for TCGA patients and validates subtype ER+/HER2+ status prediction using AUC-ROC of 0.99. It also proposes synthetic lethal gene pairs PBRM1-NF2 and PBRM1-CTNND2 for precision therapy development.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/deep-unsupervised-domain-adaptation-for-translating-cancer-dependency-maps-from-cell-lines-to-breast-cancer-tumor-genomics/355902/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/deep-unsupervised-domain-adaptation-for-translating-cancer-dependency-maps-from-cell-lines-to-breast-cancer-tumor-genomics/355902.png","ImageObject",300,407,{"name":92,"@type":93},"Jasmine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",13,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What problem does the study address?","Question",{"text":113,"@type":114},"It addresses discrepancies between cancer cell line models and patient-derived tumor models, especially for translating dependency map findings into clinical settings.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How does the proposed method work?",{"text":118,"@type":114},"It uses a deep unsupervised domain adaptation algorithm to align features between a labeled source domain and an unlabeled target domain, then predicts breast cancer dependency maps for TCGA patients.",{"name":120,"@type":111,"acceptedAnswer":121},"How was the model performance validated, and what was achieved?",{"text":122,"@type":114},"Performance was validated by predicting ER+/HER2+ breast cancer subtype statuses and synthetic lethality gene pairs for drug discovery, reaching an AUC-ROC of 0.99 for subtype prediction.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355902,1790472059,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":41,"preview_page_count":19,"preview_urls":146},2336478487870,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Genetic Epidemiology   \n RESEARCH ARTICLE   \nDeep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics  \nYu Shi1 | Wei Xu1,2 | Pingzhao Hu1,3,4,5,6   \n1Biostatistics Division, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada | 2Biostatistics Department, Princess Margaret Cancer Center, Toronto, Ontario, Canada | 3Department of Biochemistry, Western University, London, Ontario, Canada | 4Department of Computer Science, Western University, London, Ontario, Canada | 5Department of Oncology, Western University, London, Ontario, Canada | 6Department of Epidemiology and Biostatistics, Western University, London, Ontario, Canada  \nCorrespondence: Pingzhao Hu ([phu49@uwo.ca](phu49@uwo.ca))  \nReceived: 14 February 2025 | Revised: 30 March 2026 | Accepted: 13 June 2026  \nFunding: Canadian Institutes of Health Research, Grant/Award Numbers: (PLL 185683, PJT 190272, 2021‐00482; Natural Sciences and Engineering Research Council of Canada, Grant/Award Number: RGPIN‐2021‐04072  \nKeywords: breast cancer | cancer dependency map | domain adaptation | synthetic lethality | The Cancer Genome Atlas (TCGA)  \nABSTRACT  \nThe Cancer dependency maps (DepMap) identify genetic dependencies in cancer cells using large‐scale loss‐of‐function screens, providing a foundation for cancer‐specific treatment strategies. However, discrepancies exist between cancer cell line models (CCLs) and patient‐derived tumor models, particularly in translating findings to clinical settings. To bridge this gap, computational approaches such as artificial intelligence–based domain adaptation can assist in aligning laboratory and patient‐derived molecular data, thereby improving the translation of preclinical findings into personalized treatment strategies. We developed a deep unsupervised domain adaptation (UDA) algorithm to align features between source and target domains. It was trained on labeled CCLs data from the source domain and unseen, unlabeled CCL data from the target domain. The trained model was applied to predict the dependency map of breast cancer (BC) patients in The Cancer Genome Atlas (TCGA) . To validate its performance, we used the predicted BC dependency map to classify ER + /HER2 + BC subtype statuses and identify synthetic lethality (SL) gene pairs for drug discovery. Our model demonstrated high accuracy in predicting cancer dependency maps for patient‐derived tumors. The generated maps showed excellent performance in predicting ER + /HER2+ subtype statuses, with an area under the curve of the receiver operating characteristic (AUC‐ROC) of 0.99. Notably, our analysis also identified two potential synthetic lethality gene pairs: PBRM1‐NF2 and PBRM1‐CTNND2, which can be potentially used for developing precision therapies for ER + /HER2+ breast cancer. Domain adaptation is a promising approach for transferring biological knowledge between different cancer models and improving patient‐specific treatment strategies.  \n1 | Introduction  \nIn the relentless quest of combatting cancers, precision therapies have emerged as one of the promising frontiers. The development of novel cancer therapies requires knowledge of specific biological pathways to target various tumors and  \neradicate cancer cells. Most human tumors harbor numerous alterations, making it difficult to predict which genes are essential for tumor survival (Tsherniak et al. 2017) . Central to this ideology, the cancer dependency map (Broad DepMap 2022) initiative aims to systematically profile cancer cell genetic vulnerabilities or dependencies to assist the development of  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2026 The Author(s) . Genetic Epidemiology published by Wiley Periodicals L","cbCaiiqrCc4Phjs2","https://ap.wps.com/l/cbCaiiqrCc4Phjs2","pdf",3463668,12,"English","# Abstract\n# Introduction","[{\"question\":\"What problem does the study address?\",\"answer\":\"It addresses discrepancies between cancer cell line models and patient-derived tumor models, especially for translating dependency map findings into clinical settings.\"},{\"question\":\"How does the proposed method work?\",\"answer\":\"It uses a deep unsupervised domain adaptation algorithm to align features between a labeled source domain and an unlabeled target domain, then predicts breast cancer dependency maps for TCGA patients.\"},{\"question\":\"How was the model performance validated, and what was achieved?\",\"answer\":\"Performance was validated by predicting ER+/HER2+ breast cancer subtype statuses and synthetic lethality gene pairs for drug discovery, reaching an AUC-ROC of 0.99 for subtype prediction.\"}]","Deep Unsupervised Domain Adaptation for Translating Cancer Dependency Maps From Cell Lines to Breast Cancer Tumor Genomics | PDF",1790121642,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8bd5c186c6eaa2e63e5cd3f4ba7a732e.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b00fe9e9ecbf00da877d733d9346ddc2.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07fc21470e8f8e84a0c91abdb9a6ce53.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/15718985d6bcbbb202446d48ae9a1926.webp",980,1287]